Drug Shortage Report for SANDOZ IRBESARTAN
| Report ID | 78500 |
| Drug Identification Number | 02328496 |
| Brand name | SANDOZ IRBESARTAN |
| Common or Proper name | IRBESARTAN |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 500 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2018-11-01 |
| Estimated end date | 2020-10-23 |
| Actual end date | 2020-10-23 |
| Shortage status | Resolved |
| Updated date | 2020-10-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v46 | 2020-10-27 | French | Compare |
| v45 | 2020-10-27 | English | Compare |
| v44 | 2020-10-13 | French | Compare |
| v43 | 2020-10-13 | English | Compare |
| v42 | 2020-10-05 | French | Compare |
| v41 | 2020-10-05 | English | Compare |
| v40 | 2020-09-28 | French | Compare |
| v39 | 2020-09-28 | English | Compare |
| v38 | 2020-09-21 | French | Compare |
| v37 | 2020-09-21 | English | Compare |
| v36 | 2020-08-26 | French | Compare |
| v35 | 2020-08-26 | English | Compare |
| v34 | 2020-06-29 | French | Compare |
| v33 | 2020-06-29 | English | Compare |
| v32 | 2020-06-08 | French | Compare |
| v31 | 2020-06-08 | English | Compare |
| v30 | 2020-05-11 | French | Compare |
| v29 | 2020-05-11 | English | Compare |
| v28 | 2020-05-04 | French | Compare |
| v27 | 2020-05-04 | English | Compare |